Physician profile
James A Witten
NPI 1407827231
$119,310.54
in general payments reported to CMS, 2019-2025
46 companies · $3,416 in 2025
The $3,416 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $26K · 2021: $20K · 2022: $23K · 2023: $17K · 2024: $3,527 · 2025: $3,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $10K · Education: $789 · Travel and Lodging: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,000.00 |
| Food and Beverage | $10,211.45 |
| Education | $788.86 |
| Travel and Lodging | $222.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $83,615.92 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Sunovion Pharmaceuticals INC. | $9,788.13 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $4,387.54 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Genentech USA, INC. | $4,071.12 | 2019-2025 | Xolair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,152.26 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Genzyme Corporation | $1,866.53 | 2019-2025 | |
| Viiv Healthcare Company | $1,600.00 | 2019 | |
| Mallinckrodt Hospital Products INC. | $1,334.21 | 2020-2025 | Acthar, Terlivaz |
| Ani Pharmaceuticals, INC. | $1,332.90 | 2022-2025 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $1,177.61 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $949.31 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $884.48 | 2019-2024 | Yupelri |
| Novartis Pharmaceuticals Corporation | $602.51 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $558.65 | 2020-2025 | Glassia |
| United Therapeutics Corporation | $495.73 | 2019-2025 | Tyvaso, Tyvaso |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $379.17 | 2021-2025 | Tezspire |
| Insmed, INC. | $375.18 | 2019-2025 | Arikayce, Brinsupri |
| La Jolla Pharmaceutical Company | $248.24 | 2021-2025 | Giapreza |
| Grifols USA, LLC | $240.89 | 2019-2024 | Prolastin-C Liquid |
| Sanofi-Aventis U.S. LLC | $235.97 | 2023-2025 | |
| Pulmonx Corporation | $197.17 | 2022-2023 | Zephyr Delivery Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Mallinckrodt Enterprises LLC | $194.28 | 2019 | |
| Baxter Healthcare | $172.15 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Janssen Pharmaceuticals, INC | $141.24 | 2019-2023 | Xarelto |
| Inogen, INC. | $140.89 | 2019-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Electromed, INC. | $139.92 | 2019-2025 | Smartvest |
| Teva Pharmaceuticals USA, INC. | $132.55 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $115.27 | 2019-2025 | Zerbaxa, Belsomra |
| Gilead Sciences, INC. | $97.95 | 2019 | |
| Verona Pharma, INC. | $90.06 | 2025 | Ohtuvayre |
| Bayer Healthcare Pharmaceuticals INC. | $75.96 | 2021-2025 | |
| Tactile Systems Technology INC | $56.18 | 2022 | |
| Vifor Pharma, INC. | $54.84 | 2024-2025 | Zemaira |
| E.R. Squibb & Sons, L.L.C. | $50.33 | 2019-2021 | |
| Harmony Biosciences LLC | $46.54 | 2024-2025 | |
| Shire North American Group INC | $43.59 | 2019 | |
| Pfizer INC. | $40.88 | 2024 | |
| Inspire Medical Systems, INC. | $40.56 | 2024 | Inspire |
| Viatris Specialty LLC | $39.56 | 2025 | Yupelri |
| Advanced Respiratory, INC | $36.05 | 2021 | |
| Philips North America LLC | $31.47 | 2020-2024 | (Ak6) Vest Therapy |
| Tempus Ai, INC | $21.83 | 2025 | Xt Cdx |
| Pharming Healthcare, INC. | $16.37 | 2023 | Ruconest |
| Acacia Pharma INC | $16.18 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.33 | 2019 | |
| Vapotherm INC | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Witten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.